help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on October 31, 2002, doi:10.1164/rccm.200206-506OC

Am. J. Respir. Crit. Care Med., Volume 167, Number 4, February 2003, 550-556

A more recent version of this article appeared on February 15, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200206-506OCv1
167/4/550    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adamko, D. J
Right arrow Articles by Jacoby, D. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adamko, D. J
Right arrow Articles by Jacoby, D. B

Submitted on June 4, 2002
Accepted on October 24, 2002

CD8+ T-Lymphocytes in Viral Hyperreactivity and M2 Muscarinic Receptor Dysfunction

Darryl J Adamko1, Allison D Fryer2, Bruce S Bochner3, and David B Jacoby4*

1 Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada, 2 Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, 3 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA, 4 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

* To whom correspondence should be addressed. E-mail: djacoby{at}jhmi.edu.

In the airways, inhibitory M2 muscarinic receptors on parasympathetic nerves limit acetylcholine release. Viral infection causes M2 receptor dysfunction, which increases acetylcholine release and leads to airway hyperreactivity. In these studies we tested the role of CD8+ T-cells in parainfluenza virus-induced hyperreactivity and M2 receptor dysfunction in normal guinea pigs and in guinea pigs previously sensitized to ovalbumin. Depleting CD8+ T-cells prevented virus-induced M2 receptor dysfunction and hyperreactivity in sensitized animals, but not non-sensitized animals. Sensitization increased the number of eosinophils in close relation to the airway nerves where, when activated, they release major basic protein, which binds to and blocks the M2 receptor. Regardless of sensitization, virus infection decreased the number of visible tissue eosinophils, likely reflecting eosinophil degranulation via cytolysis. Depleting CD8+ T-cells prevented this virus-induced eosinophil degranulation. In addition, an antiviral effect of sensitization, which we previously showed to be eosinophil mediated, was again seen. This was prevented by depletion of CD8+ T-cells. Thus, CD8+ T-cells play a role in airway hyperreactivity and M2 receptor dysfunction of sensitized virus-infected guinea pigs by mediating eosinophil degranulation near airway nerves. In contrast, CD8+ T-cells are not necessary for virus-induced hyperreactivity and M2 receptor dysfunction in non-sensitized guinea pigs.


Key words: T-cells, eosinophils, viral immunity, asthma, airway hyperreactivity




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
E. J. Saude, I. P. Obiefuna, R. L. Somorjai, F. Ajamian, C. Skappak, T. Ahmad, B. K. Dolenko, B. D. Sykes, R. Moqbel, and D. J. Adamko
Metabolomic Biomarkers in a Model of Asthma Exacerbation: Urine Nuclear Magnetic Resonance
Am. J. Respir. Crit. Care Med., January 1, 2009; 179(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
K. E. Belmonte
Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Moorman, M. Saad, S. Kosseifi, and G. Krishnaswamy
Hepatitis C Virus and the Lung: Implications for Therapy
Chest, October 1, 2005; 128(4): 2882 - 2892.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Kanazawa, K. Hirata, and J. Yoshikawa
Increased Responses to Inhaled Oxitropium Bromide in Asthmatic Patients With Active Hepatitis C Virus Infection
Chest, April 1, 2004; 125(4): 1368 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society
  Work-Life